We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Cancer drugs.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Cancer drugs - List of Manufacturers, Suppliers, Companies and Products | IPROS GMS

Cancer drugs Product List

1～5 item / All 5 items

Displayed results
Tohoku Univ. Technology：A novel therapeutic target Vasohibin-2: T18-447_T12-072

Tohoku Univ. Technology：A novel therapeutic target Vasohibin-2: T18-447_T12-072

For the treatment of refractory cancers including pancreatic cancer

Vasohibin-2 (referred to as VASH2) knockdown significantly reduced metastasis of pancreatic cancer cells (Fig. 1) and prolonged survival period after orthotopic transplantation (Fig.2). The mechanisms of action are;　 (1)VASH2 knockdown reduces cancer cell invasion through suppressing of tubulin carboxypeptidase activity within the cell. (2) VASH2 secreted by cancer cells stimulates tumor angiogenesis, so when VASH2 was knocked down, tumor angiogenesis was prevented. (3) VASH2 regulates the production of inflammatory chemokines and cytokines in cancer cells, which in turn, accelerates the recruitment of MDSC and TAM and prevents the infiltration of cytotoxic T lymphocytes. The inhibition of VASH2 eliminates immune suppression in pancreatic cancer.

  • others
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Ovarian Cancer Treatment Drugs

[Research Material] Global Market for Ovarian Cancer Treatment Drugs

Global Market for Ovarian Cancer Treatments: PARP, PD-L1, Angiogenesis Inhibitors, Hospitals, Research

This research report (Global Ovarian Cancer Therapeutics Market) investigates and analyzes the current state and outlook for the global market for ovarian cancer therapeutics over the next five years. It includes information on the overview of the global ovarian cancer therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on PARP, PD-L1, and angiogenesis inhibitors, while the segments by application target hospitals and research. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for ovarian cancer therapeutics. It also includes the market share of major companies in the ovarian cancer therapeutics sector, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Renal Cell Carcinoma Treatment Drugs

[Research Material] Global Market for Renal Cell Carcinoma Treatment Drugs

Global Market for Renal Cell Carcinoma Treatments: Somatostatin Analogues, Targeted Therapies, Chemotherapy, Hospitals, Clinics, Oncology Centers

This research report (Global Renal Cell Carcinoma Drugs Market) investigates and analyzes the current status and outlook for the global market of renal cell carcinoma treatment drugs over the next five years. It includes information on the overview of the global renal cell carcinoma treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include somatostatin analogs, targeted therapies, and chemotherapy, while the segments by application focus on hospitals, clinics, and oncology centers. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of renal cell carcinoma treatment drugs. It also includes the market share of major companies in renal cell carcinoma treatment drugs, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Adrenal Cortical Cancer Treatment Drugs

[Research Material] Global Market for Adrenal Cortical Cancer Treatment Drugs

World Market for Adrenal Cortical Carcinoma Treatment Drugs: Chemotherapy, Targeted Therapy, Hospitals, Research Institutions, Clinics, Others

This research report (Global Adrenocortical Carcinoma Drugs Market) investigates and analyzes the current status and outlook for the global market for drugs used to treat adrenocortical cancer over the next five years. It includes information on the overview of the global adrenocortical cancer drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on chemotherapy and targeted therapy, while the segments by application target hospitals, research institutions, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for adrenocortical cancer drugs. It also includes the market share of major companies in the adrenocortical cancer drug market, product and business overviews, and sales performance.

  • Other services
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Skin Cancer Treatment

[Market Report] Global Market for Skin Cancer Treatment

The global market for skin cancer treatment is rapidly expanding and is expected to reach 14.5 billion USD by 2031.

As the battle against skin cancer, one of the most common cancers, continues, the global skin cancer treatment market is emerging as a bastion of hope. This market recorded a solid revenue of approximately 7.72 billion USD in 2022 and is expected to achieve a compound annual growth rate (CAGR) of 7.3% during the forecast period from 2023 to 2031, indicating remarkable growth. By 2031, it is projected to reach an astonishing valuation of 14.5 billion USD. Skin cancer is often caused by excessive sunbathing and ultraviolet rays, and there is growing global concern about it. The rising incidence of skin cancer and increasing awareness of the importance of early diagnosis and treatment are driving demand for advanced and effective skin cancer treatment options. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others
  • Cancer drugs

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Related Categories of Cancer drugs

COPYRIGHT © 2001-2026 IPROS CORPORATION ALL RIGHTS RESERVED.